The european society for medical oncology (esmo) has updated its guidelines, with some outlets reporting changes related to ovarian cancer, while others mention updates to guidelines for metastatic breast cancer and urothelial cancer. It is unclear which specific cancer type's guidelines have been updated, as reports vary. Some outlets also discuss recent studies and research in ovarian and other cancers, including potential biomarkers and treatment strategies.